MedAvail Holdings, Inc.
MDVL · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | 0.05 | 0.14 |
| FCF Yield | -20.30% | -22.69% | -44.82% | -19.22% |
| EV / EBITDA | -1.81 | -0.52 | -1.83 | -4.75 |
| Quality | ||||
| ROIC | -18.08% | -22.65% | -38.51% | -27.11% |
| Gross Margin | 43.95% | 41.45% | -1.11% | 11.27% |
| Cash Conversion Ratio | 0.76 | 0.30 | 0.94 | 0.98 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.28% | 27.80% | 45.59% | 51.54% |
| Free Cash Flow Growth | 14.46% | 51.57% | 8.07% | 11.89% |
| Safety | ||||
| Net Debt / EBITDA | 2.20 | 1.32 | 0.41 | 1.54 |
| Interest Coverage | -30.51 | -29.65 | -32.86 | -36.48 |
| Efficiency | ||||
| Inventory Turnover | 0.02 | 0.04 | 1.65 | 1.59 |
| Cash Conversion Cycle | 3,739.82 | 1,964.68 | 58.78 | 56.66 |